Added to YB: 2026-02-19
Pitch date: 2026-02-16
VME.DE [bullish]
Viromed Medical AG
-5.48%
current return
Author Info
PPinvest is an Ex-Citibanker who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology.
Market Cap
EUR 150.9M
Pitch Price
EUR 7.30
Price Target
18.40 (+173%)
Dividend
N/A
EV/EBITDA
-499.36
P/E
249.59
EV/Sales
29.59
Sector
Health Care Providers and Services
Category
growth
Why the whole world is waiting for Viromed Medical $VME - Lots of TAM – TAM
VME.DE: German medtech w/ PulmoPlas using cold plasma to kill antibiotic-resistant bacteria in lungs. MHH study validates efficacy & safety. Sales projected to jump from €1.4M (2024) to €80M (2026). TAM: 216k hospitals globally, €150M+ in Germany alone. Razor-blade model w/ recurring consumables. Asia deal: €150M+ by 2028. Price target €18.4 (+190%) in 3yrs on 25.8x fair P/E vs 10x current.
Read full article (4 min)